These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


279 related items for PubMed ID: 6337172

  • 1. 19-nor-deoxycorticosterone excretion in primary aldosteronism and low renin hypertension.
    Griffing GT, Dale SL, Holbrook MM, Melby JC.
    J Clin Endocrinol Metab; 1983 Feb; 56(2):218-21. PubMed ID: 6337172
    [Abstract] [Full Text] [Related]

  • 2. The regulation of urinary free 19-nor-deoxycorticosterone and its relation to systemic arterial blood pressure in normotensive and hypertensive subjects.
    Griffing GT, Dale SL, Holbrook MM, Melby JC.
    J Clin Endocrinol Metab; 1983 Jan; 56(1):99-103. PubMed ID: 6292258
    [Abstract] [Full Text] [Related]

  • 3. Prohormones in adrenal venous effluent in patients with primary hyperaldosteronism.
    Rao A, Melby JC, Wilson TE.
    J Clin Endocrinol Metab; 1995 May; 80(5):1677-80. PubMed ID: 7745017
    [Abstract] [Full Text] [Related]

  • 4. Relationship of 19-nor-deoxycorticosterone to other mineralocorticoids in low-renin hypertension.
    Griffing GT, Dale SL, Holbrook MM, Melby JC.
    Hypertension; 1983 May; 5(3):385-9. PubMed ID: 6341221
    [Abstract] [Full Text] [Related]

  • 5. Urinary free 19-nor-deoxycorticosterone and deoxycorticosterone in human hypertension.
    Gomez-Sanchez CE, Holland OB, Upcavage R.
    J Clin Endocrinol Metab; 1985 Feb; 60(2):234-8. PubMed ID: 3880766
    [Abstract] [Full Text] [Related]

  • 6. Urinary kallikrein excretion in patients with primary aldosteronism: differentiation of adrenal adenoma from idiopathic adrenal hyperplasia.
    Nakada T.
    Urol Int; 1984 Feb; 39(1):40-5. PubMed ID: 6375065
    [Abstract] [Full Text] [Related]

  • 7. [Aldosterone precursors and hypertension with hypokalemia and adrenal module non caused by primary hyperaldosteronism].
    Chamontin B, Blanchouin-Emeric N, Amar J, Khatibi F, Vernier I, Bennet A, Aupetit-Faisant B, Salvador M.
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1055-8. PubMed ID: 8949378
    [Abstract] [Full Text] [Related]

  • 8. Elevated urinary 19-Nor-deoxycorticosterone glucuronide in Cushing's syndrome.
    Ehlers ME, Griffing GT, Wilson TE, Melby JC.
    J Clin Endocrinol Metab; 1987 May; 64(5):926-30. PubMed ID: 3558730
    [Abstract] [Full Text] [Related]

  • 9. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension?
    Komiya I, Yamada T, Aizawa T, Takasu N, Niwa A, Maruyama Y, Ogawa A.
    Cardiology; 1991 May; 78(2):99-110. PubMed ID: 2070375
    [Abstract] [Full Text] [Related]

  • 10. Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism.
    Kater CE, Biglieri EG, Schambelan M, Arteaga E.
    Hypertension; 1983 May; 5(6 Pt 3):V115-21. PubMed ID: 6360878
    [Abstract] [Full Text] [Related]

  • 11. Unconjugated and conjugated urinary 19-nor-deoxycorticosterone glucosiduronate. Elevated levels in essential hypertension.
    Griffing GT, Wilson TE, Melby JC.
    Hypertension; 1985 May; 7(3 Pt 2):I12-7. PubMed ID: 3873413
    [Abstract] [Full Text] [Related]

  • 12. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP, Ragazzo F, Seccia TM, Maniero C, Barisa M, Calò LA, Frigo AC, Fassina A, Pessina AC.
    Hypertension; 2012 Aug; 60(2):431-6. PubMed ID: 22733469
    [Abstract] [Full Text] [Related]

  • 13. Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia.
    Wu VC, Chueh SC, Chang HW, Lin WC, Liu KL, Li HY, Lin YH, Wu KD, Hsieh BS.
    QJM; 2008 Jan; 101(1):13-22. PubMed ID: 18203722
    [Abstract] [Full Text] [Related]

  • 14. Low renin essential hypertension: failure to demonstrate excess 11-deoxycorticosterone production.
    Tan SY, Mulrow PJ.
    J Clin Endocrinol Metab; 1979 Nov; 49(5):790-3. PubMed ID: 489719
    [Abstract] [Full Text] [Related]

  • 15. Plasma and urinary 19-nor-deoxycorticosterone in 17 alpha-hydroxylase deficiency syndrome.
    Griffing GT, Wilson TE, Holbrook MM, Dale SL, Jackson TK, Ullrich I, Melby JC.
    J Clin Endocrinol Metab; 1984 Nov; 59(5):1011-5. PubMed ID: 6332824
    [Abstract] [Full Text] [Related]

  • 16. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL, Zeng ZP, Tong AL, Lu L, Chen S, Li M, Fu CL, Wang YH, Sun ML.
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [Abstract] [Full Text] [Related]

  • 17. Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma.
    Olivieri O, Cecconi D, Castagna A, Chiecchi L, Guarini P, Gunasekaran M, Morandini F, Brazzarola P, Zolla L, D'Alessandro A, Veglio F, Mulatero P, Pizzolo F.
    Mol Biosyst; 2014 Jun; 10(6):1281-9. PubMed ID: 24503858
    [Abstract] [Full Text] [Related]

  • 18. Response of several adrenal steroids to ACTH stimulation in essential hypertension.
    Honda M, Nowaczynski W, Guthrie GP, Messerli FH, Tolis G, Kuchel O, Genest J.
    J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252
    [Abstract] [Full Text] [Related]

  • 19. Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes.
    Kline GA, Pasieka JL, Harvey A, So B, Dias VC.
    Ann Surg Oncol; 2013 Jul; 20(7):2274-8. PubMed ID: 23504117
    [Abstract] [Full Text] [Related]

  • 20. Role of 18-hydroxy-11-deoxycorticosterone and 16 alpha, 18-dihydroxy-11-deoxycorticosterone in hypertension.
    Melby JC, Dale SL.
    Mayo Clin Proc; 1977 May; 52(5):317-22. PubMed ID: 870774
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.